Skip to main content
. Author manuscript; available in PMC: 2017 Dec 15.
Published in final edited form as: J Infect Dis. 2016 Aug 28;214(10):1477–1486. doi: 10.1093/infdis/jiw380

Table 2.

Influenza Virus Vaccine Strain–Specific Hemagglutination-Inhibition (HI) Titers Among Children Vaccinated With 2010–2011 Trivalent Inactivated Influenza Vaccine, Overall and by Receipt of 2009–2010 Seasonal Influenza Vaccine

Variable A(H1N1) Strain, Titer
A(H3N2) Strain, Titer
B Strain, Titer
A(H1N1)pdm09
A/Bris/59
A/Perth/16
A/Bris/10
B/Bris/60
B/Flor/4
Overall No
Receipt
Receipt Overall No
Receipt
Receipt Overall No
Receipt
Receipt Overall No
Receipt
Receipt Overall No
Receipt
Receipt Overall No
Receipt
Receipt
Fold-rise > 4

 28 d 86.0 4.0 70.0 68.0 64.0 30.0

HI > 40

 0 d 68.0 66.7 68.4 42.0 13.3a 84.2 30.0 6.7a 63.2 64.0 40.0a 100.0 50.0 30.0a 78.9 60.0 53.3 68.4

 28 d 96.0 96.7 94.7 44.0 20.0a 78.9 84.0 76.7 94.7 94.0 90.0 100.0 96.0 100.0 89.5 80.0 83.3 73.7

 7 mo 95.9 96.7 94.4 38.8 16.7a 72.2 73.5 70.0 77.8 85.7 80.0 94.4 91.8 93.3 88.9 63.3 63.3 61.1

HI > 80

 0 d 36.0 30.0 47.7 26.0 6.7a 52.6 22.0 3.3a 47.4 50.0 20.0a 94.7 36.0 20.0b 57.9 42.0 30.0 57.9

 28 d 92.0 93.3 89.5 30.0 13.3b 52.6 74.0 66.7 84.2 90.0 83.3 100.0 88.0 90.0 84.2 70.0 73.3 63.2

 7 mo 87.8 83.3 94.4 22.4 6.7b 44.4 55.1 56.7 50.0 83.7 76.7 94.4 77.6 80.0 72.2 51.0 50.0 50.0

HI > 160

 0 d 14.0 13.3 15.8 16.0 6.7 26.3 14.0 3.3c 31.6 38.0 10.0a 78.9 18.0 16.7 21.1 28.0 20.0 42.1

 28 d 86.0 86.7 84.2 16.0 6.7 26.3 66.0 56.7 78.9 84.0 76.7 94.7 70.0 73.3 63.2 52.0 53.3 52.6

 7 mo 67.3 66.7 66.7 14.3 6.7 22.2 40.8 33.3 50.0 67.3 63.3 72.2 38.8 43.3 27.8 36.7 36.7 38.9

The influence of prior seasonal vaccination on the percentage of subjects with HI titers of ≥ 40, 80, and 160 were assessed using the Fisher exact test for each virus strain. 2009 pandemic influenza A(H1N1) (A[H1N1]pdm09), A/Perth/16, and B/Bris/60 were included in the 2010–2011 TIV; A/Bris/59, A/Bris10, and B/Bris/60 were included in the 2009–2010 TIV; and B/Flor/4 was included in the 2008–2009 TIV.

Significance is indicated by

a

P ≤ .001 vs recipients of TIV containing the specified strain.

b

P ≤ .01 vs recipients of TIV containing the specified strain.

c

P ≤ .05 vs recipients of TIV containing the specified strain.